Patents by Inventor Peter G. Linde

Peter G. Linde has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210346464
    Abstract: Provided herein are methods for treatment of anemia due to very low, low, or intermediate risk myelodysplastic syndromes in subjects with ring sideroblasts by subcutaneous administration of an ActRIIA or ActRIIB ligand trap.
    Type: Application
    Filed: October 30, 2019
    Publication date: November 11, 2021
    Inventors: Abderrahmane Laadem, Xianjuan Zhang, Kenneth M. Attie, Peter G. Linde
  • Publication number: 20100125235
    Abstract: Blood treatment apparatus comprise an enclosure having one or more blood treatment modules, typically, hollow fiber bundles, therein. A blood flow inlet distribution network divides an inlet blood flow into a series of successive individual blood flow stages in order to increase uniformity of the distribution of the blood flow into the hollow fiber bundles. The inlet blood flow may be divided in two, three, four, or more stages, providing a large number of end stage flow channels to feed blood into the hollow fiber bundle.
    Type: Application
    Filed: June 15, 2009
    Publication date: May 20, 2010
    Applicant: Triaxis Medical Devices, Inc.
    Inventors: Thomas H. Cauley, III, Peter G. Linde, Gregory G. Raleigh
  • Patent number: 7338461
    Abstract: Methods and devices are provided that improve the function of organ support devices, and also provided are improved methods of treating conditions associated with hemodynamic instability.
    Type: Grant
    Filed: February 2, 2005
    Date of Patent: March 4, 2008
    Assignee: The General Hospital Corporation
    Inventors: Peter G. Linde, Winfred W. Williams
  • Patent number: 6458588
    Abstract: Flk-1 positive/Sca-1 negative renal stems cells and uses thereof are described. The cells are useful for the regeneration of damaged kidney tissue, the generation of artificial kidneys and the delivery of transgenes.
    Type: Grant
    Filed: April 5, 2001
    Date of Patent: October 1, 2002
    Assignee: The General Hospital Corporation
    Inventors: M. Amin Arnaout, Peter G. Linde
  • Publication number: 20020102241
    Abstract: Flk-1 positive/Sca-1 negative renal stems cells and uses thereof are described. The cells are useful for the regeneration of damaged kidney tissue, the generation of artificial kidneys and the delivery of transgenes.
    Type: Application
    Filed: April 5, 2001
    Publication date: August 1, 2002
    Inventors: M. Amin Arnaout, Peter G. Linde